Tuberculosis patients across the country received the benefit so far under the Direct Benefit Transfer (DBT) scheme. More than 8 lakh tuberculosis patients registered under Nikshay Poshan Yojana (NPY) have benefitted, said Minister of State Health and Family Welfare Ashwini Kumar Choubey.
"As on January 1, 2019, out of 20.94 lakhs eligible beneficiaries, 8.78 lakh (42%) beneficiaries have received the benefit under the scheme," the minister stated in a written reply in the Lok Sabha.
Tuberculosis
Tuberculosis, caused by Mycobacterium tuberculosis, primarily affects the lung. It may spread to other organs.
Advertisement
‘Flexibility in the payment of benefits to the TB beneficiaries has been provided to the States/UTs by the Central Government.’
Tweet it Now
The Minister also stated that the ministry has provided detailed guidance to the states and UTs on how DBT is to be operationalized.
"State/UTs have been given different payment options as per their convenience for either making payment directly through Public Financial Management System (PFMS) or through the Nikshay PFMS interface," he added.
![Screening Tests for Tuberculosis]( "Screening Tests for Tuberculosis")
Tuberculin skin test and Interferon - Release Assays are tests used to screen for tuberculosis.
"Flexibility of providing the benefit through existing bank account of a blood relative has also been given. State have also been advised to facilitate opening of zero balance accounts for TB patients, if necessary, under the Pradhan Mantri Jan Dhan Yojana (PMJDY) and Indian Postal Bank," Choubey said.
Source: IANS
Screening Tests for Tuberculosis
Tuberculin skin test and Interferon - Release Assays are tests used to screen for tuberculosis.
Advertisement
"Flexibility of providing the benefit through existing bank account of a blood relative has also been given. State have also been advised to facilitate opening of zero balance accounts for TB patients, if necessary, under the Pradhan Mantri Jan Dhan Yojana (PMJDY) and Indian Postal Bank," Choubey said.
Source: IANS
Drug-Resistant Tuberculosis
Drug-resistant tuberculosis (TB) is a globally serious infectious disease caused by the bacterium Mycobacterium tuberculosis. It occurs as multidrug-resistant or MDR TB or in its more severe form, extensively drug-resistant or XDR TB.
Advertisement
 Extra Pulmonary TuberculosisExtra pulmonary tuberculosis is infection of tissues and organs other than the lungs by mycobacterium tuberculosis and related organisms. | Advertisement
|
Advertisement
Recommended Reading
Latest Indian Health News
What is latent Tuberculosis infection? Latent Tuberculosis is one related condition that occurs when the individual infected with Tuberculosis bacteria does not show any symptoms.
Experts note a rising trend in brain diseases among youngsters in India, causing concern.
H3N2 Outbreak in India: Influenza and respiratory illnesses are spreading faster than ever before in India. Finding ways for better lung health can save lives from deadly viruses.
Is stroke common in India? Yes, a stroke kills one Indian every 4 minutes. Therefore, telemedicine in stroke treatment could save lives.
Across Karnataka, more than 50 cases of H3N2 have been reported. Karnataka government released detailed guidelines in this regard.